[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1976

ClofazimineA New Agent for the Treatment of Pyoderma Gangrenosum

Author Affiliations

From the departments of dermatology, Uppsala University Hospital, Uppsala (Drs Michaëlsson, Öhman, and Trolin), Linköping University Hospital, Linköping (Drs Molin and Skogh), Sundsvall Hospital, Sundsvall (Dr Gip), and Falun Hospital, Falun (Dr Lindström), Sweden.

Arch Dermatol. 1976;112(3):344-349. doi:10.1001/archderm.1976.01630270024006
Abstract

• Eight patients had pyoderma gangrenosum. They were given a phendimetrazine tartrate derivative, clofazimine (Lamprene [Britain]), which is a chemotherapeutic agent used mainly in certain mycobacterial infections and which also has phagocytosis-enhancing properties. The effect of this drug was remarkably good, with rapid healing of the lesions commencing 3 to 14 days after treatment was started. The mechanism for the effect of clofazimine in pyoderma gangrenosum is not known.

(Arch Dermatol 112:344-349, 1976)

×